Inactive Instrument
HedgePath Pharmaceuticals Inc Stock
Stocks
US42278K1025
Biotechnology & Medical Research
| 1 day | -27.42% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 76 | 13/12/2022 | |
James McNulty
DFI | Director of Finance/CFO | 76 | 13/12/2022 |
Simon Bettink
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 76 | 13/12/2022 | |
Niraj Vasisht
BRD | Director/Board Member | 62 | 13/12/2022 |
Samuel Sears
BRD | Director/Board Member | 82 | 02/08/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -27.42% | -3.08% | - | - | 32.23M | |
| +0.22% | -3.17% | -1.61% | +8.24% | 45.81B | |
| -4.36% | -5.66% | +338.30% | +533.43% | 43.91B | |
| -0.32% | +4.61% | +43.90% | +28.41% | 44.39B | |
| +0.46% | -0.83% | +6.38% | +66.62% | 39.4B | |
| -0.17% | -3.22% | +9.45% | +38.69% | 31.26B | |
| +3.30% | -5.03% | - | - | 15.75B | |
| -0.65% | +5.14% | +25.61% | +125.72% | 17.32B | |
| +1.66% | +4.92% | +18.42% | +34.93% | 14.73B | |
| +0.19% | -1.77% | +80.35% | +29.84% | 13.03B | |
| Average | -2.73% | -1.08% | +65.10% | +108.24% | 29.51B | |
| Weighted average by Cap. | -0.47% | -1.10% | +76.20% | +127.99% |
Employees
-
